Published ahead of print on October 29, 2004, doi:10.1164/rccm.200406-804OC
American Journal of Respiratory and Critical Care Medicine Vol 171. pp. 275-281, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200406-804OC
Sildenafil Inhibits Altitude-induced Hypoxemia and Pulmonary Hypertension
Jean-Paul Richalet,
Pierre Gratadour,
Paul Robach,
Isabelle Pham,
Michèle Déchaux,
Aude Joncquiert-Latarjet,
Pascal Mollard,
Julien Brugniaux and
Jérémy Cornolo
Laboratoire Réponses cellulaires et fonctionnelles à l'hypoxie, Université Paris 13, Bobigny; Service de Physiologie et Explorations Fonctionnelles, hôpital Avicenne, Bobigny; Service d'Anesthésie-réanimation, hôpital Hôtel Dieu, Lyon; Service de Physiologie, hôpital Jean-Verdier, Bondy; Ecole Nationale de Ski et d'Alpinisme, Chamonix; Laboratoire de Physiologie, hôpital Necker, Paris, France
Correspondence and requests for reprints should be addressed to Jean-Paul Richalet, M.D., Ph.D., UFR. SMBH, 74 rue Marcel Cachin, 93017 Bobigny Cedex, France. E-mail: richalet{at}smbh.univ-paris13.fr
Exposure to high altitude induces pulmonary hypertension that may lead to life-threatening conditions. In a randomized, double-blind, placebo-controlled study, the effects of oral sildenafil on altitude-induced pulmonary hypertension and gas exchange in normal subjects were examined. Twelve subjects (sildenafil [SIL] n = 6; placebo [PLA] n = 6) were exposed for 6 days at 4,350 m. Treatment (3 x 40 mg/day) was started 6 to 8 hours after arrival from sea level to high altitude and maintained for 6 days. Systolic pulmonary artery pressure (echocardiography) increased at high altitude before treatment (+29% versus sea level, p < 0.01), then normalized in SIL (6% versus sea level, NS) and remained elevated in PLA (+21% versus sea level, p < 0.05). Pulmonary acceleration time decreased by 27% in PLA versus 6% in SIL (p < 0.01). Cardiac output and systemic blood pressures increased at high altitude then decreased similarly in both groups. PaO2 was higher and alveolar-arterial difference in O2 lower in SIL than in PLA at rest and exercise (p < 0.05). The altitude-induced decrease in maximal O2 consumption was smaller in SIL than in PLA (p < 0.05). Sildenafil protects against the development of altitude-induced pulmonary hypertension and improves gas exchange, limiting the altitude-induced hypoxemia and decrease in exercise performance.
Key Words: cardiac output exercise gas exchange hypoxia
This article has been cited by other articles:

|
 |

|
 |
 
K. Howell, C. M. Costello, M. Sands, I. Dooley, and P. McLoughlin
L-Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol,
June 1, 2009;
296(6):
L1042 - L1050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Caretti, P. Bianciardi, R. Ronchi, M. Fantacci, M. Guazzi, and M. Samaja
Phosphodiesterase-5 Inhibition Abolishes Neuron Apoptosis Induced by Chronic Hypoxia Independently of Hypoxia-Inducible Factor-1{alpha} Signaling
Experimental Biology and Medicine,
October 1, 2008;
233(10):
1222 - 1230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Dempsey, D. C. McKenzie, H. C. Haverkamp, and M. W. Eldridge
Update in the Understanding of Respiratory Limitations to Exercise Performance in Fit, Active Adults
Chest,
September 1, 2008;
134(3):
613 - 622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Wilkins, J. Wharton, F. Grimminger, and H. A. Ghofrani
Phosphodiesterase inhibitors for the treatment of pulmonary hypertension
Eur. Respir. J.,
July 1, 2008;
32(1):
198 - 209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pun and L. V. Ghimire
Reducing the Incidence of High-Altitude Pulmonary Edema
Ann Intern Med,
April 17, 2007;
146(8):
613 - 613.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maggiorini and H. Mairbaurl
Reducing the Incidence of High-Altitude Pulmonary Edema
Ann Intern Med,
April 17, 2007;
146(8):
613 - 614.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Jonk, I. P. van den Berg, I. M. Olfert, D. W. Wray, T. Arai, S. R. Hopkins, and P. D. Wagner
Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise
J. Physiol.,
March 15, 2007;
579(3):
909 - 921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Spooner, J. L. Olin, and R. J. Debellis
Pharmacotherapy of High-Altitude Illness
American Journal of Lifestyle Medicine,
March 1, 2007;
1(2):
129 - 141.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maggiorini, H.-P. Brunner-La Rocca, S. Peth, M. Fischler, T. Bohm, A. Bernheim, S. Kiencke, K. E. Bloch, C. Dehnert, R. Naeije, et al.
Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial.
Ann Intern Med,
October 3, 2006;
145(7):
497 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Fesler, A. Pagnamenta, B. Rondelet, F. Kerbaul, and R. Naeije
Effects of sildenafil on hypoxic pulmonary vascular function in dogs
J Appl Physiol,
October 1, 2006;
101(4):
1085 - 1090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Roizenblatt, C. Guilleminault, D. Poyares, F. Cintra, A. Kauati, and S. Tufik
A Double-blind, Placebo-Controlled, Crossover Study of Sildenafil in Obstructive Sleep Apnea.
Arch Intern Med,
September 18, 2006;
166(16):
1763 - 1767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Hsu, K. E. Barnholt, N. K. Grundmann, J. H. Lin, S. W. McCallum, and A. L. Friedlander
Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia
J Appl Physiol,
June 1, 2006;
100(6):
2031 - 2040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jaillard, B. Larrue, P. Deruelle, A. Delelis, T. Rakza, G. Butrous, and L. Storme
Effects of Phosphodiesterase 5 Inhibitor on Pulmonary Vascular Reactivity in the Fetal Lamb
Ann. Thorac. Surg.,
March 1, 2006;
81(3):
935 - 942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Hoeper and L. J. Rubin
Update in pulmonary hypertension 2005.
Am. J. Respir. Crit. Care Med.,
March 1, 2006;
173(5):
499 - 505.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Berger, C. Hesse, C. Dehnert, H. Siedler, P. Kleinbongard, H. J. Bardenheuer, M. Kelm, P. Bartsch, and W. E. Haefeli
Hypoxia Impairs Systemic Endothelial Function in Individuals Prone to High-Altitude Pulmonary Edema
Am. J. Respir. Crit. Care Med.,
September 15, 2005;
172(6):
763 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wharton, J. W. Strange, G. M. O. Moller, E. J. Growcott, X. Ren, A. P. Franklyn, S. C. Phillips, and M. R. Wilkins
Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells
Am. J. Respir. Crit. Care Med.,
July 1, 2005;
172(1):
105 - 113.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|